Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

AstraZeneca, Moderna Rise Premarket; Nikola Falls

Published 03/16/2021, 07:58 AM
Updated 03/16/2021, 07:59 AM
© Reuters

© Reuters

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Tuesday, March 16th. Please refresh for updates.

  • AstraZeneca (NASDAQ:AZN) ADR rose 2.8% after Canada gave its approval for the drug maker’s Covid-19 vaccine to be used on its population aged 65 and over. Australia also said overnight it will proceed as planned with distributing the vaccine. This comes despite a number of European countries suspending their use of the vaccine over worries of blood clots. 

  • Moderna (NASDAQ:MRNA) stock rose 3% after the drugmaker announced it has begun dosing children aged six months to less than 12 years in a mid-to-late stage study of its Covid-19 vaccine.

  • Facebook (NASDAQ:FB) stock rose 0.3% after the social media giant reached a deal with News Corp (NASDAQ:NWSA), up 1.5%, over a content-supply deal in Australia, potentially ending a recent dispute.
  • Alibaba (NYSE:BABA) ADR fell 0.9% after Reuters reported that the company’s UC web and smartphone browser has been removed from Chinese app stores, a day after it was criticized on Chinese state television’s annual consumer rights show.
  • GameStop (NYSE:GME) stock fell 10%, continuing Monday’s slump, when trading on the stock was halted Monday due to its volatility.

  • Tilray (NASDAQ:TLRY) stock rose 3.1%, Aphria (NASDAQ:APHA) stock rose 2.6% and Canopy Growth (NASDAQ:CGC) climbed 1.5% after Governor Andrew Cuomo said Monday that New York was “very close” to legalizing cannabis for recreational use.

  • Nikola (NASDAQ:NKLA) stock fell 3.1% after the electric truck manufacturer announced a $100 million common stock offering in an SEC filing, to be used primarily to invest in funding the company’s Arizona manufacturing facility.
  • Natwest (NYSE:NWG) stock fell 2.7% after Britain's financial regulator launched criminal action against the bank over allegations it failed to detect suspicious activity by a customer depositing nearly 400 million pounds ($553 million) over five years, mostly in cash.

  • Maxar Technologies (NYSE:MAXR) stock fell 3.4% after the space technology company announced a common stock offering of $400 million in an SEC filing.

  • Fintech Acquisition Corp V (NASDAQ:FTCV) stock rose 10% after the special purpose acquisition company has agreed a deal to take public EToro, a rival of online brokerage Robinhood.

 

Latest comments

1 ٢ف
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.